Navigation Links
Aerovance Secures $20 Million in Debt Financing
Date:3/28/2008

BERKELEY, Calif., March 28 /PRNewswire/ -- Aerovance Inc. today announced it has secured $20 million in venture debt financing. Oxford Finance Corporation led the syndicate, which includes Silicon Valley Bank and Comerica Bank. Aerovance drew down $10 million from the financing line at closing. The remaining $10 million is available upon the achievement of corporate milestones.

"This financing reflects continued interest and enthusiasm in Aerovance and our clinical programs," said Mark Perry, Aerovance's president and chief executive officer. "With this additional capital, we will continue to pursue our strategic goals, including a global partnership for our lead program, Aerovant(TM), and to build value in the company through development of our respiratory and inflammatory disease candidates."

Aerovant(TM) is a recombinant human IL-4 variant that is a potent inhibitor of both the IL-4 and IL-13 receptors. Aerovance acquired the worldwide rights to the drug candidate when the company was formed as a spin-out of Bayer Pharmaceuticals Corporation in 2004.

Aerovance Inc. is a Berkeley, Calif.-based biopharmaceutical company focused on the development and commercialization of breakthrough therapies for the treatment of respiratory and inflammatory diseases. For more information, visit http://www.aerovance.com.


'/>"/>
SOURCE Aerovance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amarin Secures Global Intellectual Property Rights for Lipid Programs
2. Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs
3. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
4. Taligen Therapeutics Secures Series B Financing
5. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
6. Dendreon Secures $130 Million Committed Equity Financing Facility
7. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
8. Altheus Therapeutics Secures $3.6 Million in Venture Capital
9. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
10. Hyperion Therapeutics Secures $40 Million In Series B Round
11. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):